The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Mode of Action in Relevance of Rodent Liver Tumors to Human Cancer Risk
Abstract
Hazard identification and risk assessment paradigms depend on the presumption of the similarity of rodents to humans, yet species specific responses, and the extrapolation of high-dose effects to low-dose exposures can affect the estimation of human risk from rodent data. As a consequence, a human relevance framework concept was developed by the International Programme on Chemical Safety (IPCS) and International Life Sciences Institute (ILSI) Risk Science Institute (RSI) with the central tenet being the identification of a mode of action (MOA). To perform a MOA analysis, the key biochemical, cellular, and molecular events need to first be established, and the temporal and dose-dependent concordance of each of the key events in the MOA can then be determined. The key events can be used to bridge species and dose for a given MOA. The next step in the MOA analysis is the assessment of biological plausibility for determining the relevance of the specified MOA in an animal model for human cancer risk based on kinetic and dynamic parameters. Using the framework approach, a MOA in animals could not be defined for metal overload. The MOA for phenobarbital (PB)-like P450 inducers was determined to be unlikely in humans after kinetic and dynamic factors were considered. In contrast, after these factors were considered with reference to estrogen, the conclusion was drawn that estrogen-induced tumors were plausible in humans. Finally, it was concluded that the induction of rodent liver tumors by porphyrogenic compounds followed a cytotoxic MOA, and that liver tumors formed as a result of sustained cytotoxicity and regenerative proliferation are considered relevant for evaluating human cancer risk if appropriate metabolism occurs in the animal models and in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Casarett and Doull's Toxicology: The Basic Science of Poisons
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_2 · Cited by 3,302
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
The Role of Oxidative Stress in Carcinogenesis
Klaunig, J. E., & Kamendulis, L. M. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121851 · Cited by 1,533
Self-citationThe nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism
Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., & Moore, D. D. (2000) · Nature · doi:10.1038/35038112 · Cited by 654
PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M., et al. (2003) · Critical Reviews in Toxicology · doi:10.1080/713608372 · Cited by 611
Self-citationUeda, A., Hamadeh, H. K., Webb, H. K., Yamamoto, Y., Sueyoshi, T., Afshari, C. A., Lehmann, J. M., & Negishi, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.1 · Cited by 466
A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action
Meek, M. E. (., Bucher, J. R., Cohen, S. M., Dellarco, V., Hill, R. N., Lehman-McKeeman, L. D., Longfellow, D. G., Pastoor, T., Seed, J., & Patton, D. E. (2003) · Critical Reviews in Toxicology · doi:10.1080/713608373 · Cited by 444
Self-citationIron, hemochromatosis, and hepatocellular carcinoma
Kowdley, K. V. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.019 · Cited by 391
Sugatani, J., Kojima, H., Ueda, A., Kakizaki, S., Yoshinari, K., Gong, Q.-H., Owens, I. S., Negishi, M., & Sueyoshi, T. (2001) · Hepatology · doi:10.1053/jhep.2001.24172 · Cited by 381
IPCS Conceptual Framework for Evaluating a Mode of Action for Chemical Carcinogenesis
Sonich-Mullin, C., Fielder, R., Wiltse, J., Baetcke, K., Dempsey, J., Fenner-Crisp, P., Grant, D., Hartley, M., Knaap, A., Kroese, D., et al. (2001) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2001.1493 · Cited by 352
Yamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M., & Maronpot, R. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1459 · Cited by 350
Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis
Bartsch, H., & Nair, J. (2004) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2004.07.004 · Cited by 274
Whysner, J. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(96)00067-8 · Cited by 233
Etheno DNA-base adducts from endogenous reactive species
Nair, J., Barbin, A., Velic, I., & Bartsch, H. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00008-1 · Cited by 210
Evaluating the Human Relevance of Chemically Induced Animal Tumors
Cohen, S. M. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh073 · Cited by 163
Self-citationTarget Organs in Chronic Bioassays of 533 Chemical Carcinogens
Gold, L. S., Slone, T. H., Manley, N. B., & Bernstein, L. (1991) · Environmental Health Perspectives · doi:10.1289/ehp.9193233 · Cited by 128
Functional and structural comparison of PXR and CAR
Moore, J. T., Moore, L. B., Maglich, J. M., & Kliewer, S. A. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00481-6 · Cited by 119
The Human Relevance of Information on Carcinogenic Modes of Action: Overview
Cohen, S. M., Meek, M. E., Klaunig, J. E., Patton, D. E., & Fenner-Crisp, P. A. (2003) · Critical Reviews in Toxicology · doi:10.1080/713608371 · Cited by 94
Self-citationParzefall, W., Erber, E., Sedivy, R., & Schulte‐Hermann, R. (1991) · PubMed · Cited by 87
Epigenetic carcinogens: Evaluation and risk assessment
Williams, G. M., & Whysner, J. A. (1996) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(96)80041-8 · Cited by 71
Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants
Pirttiaho, H. I., Sotaniemi, E. A., Pelkonen, R. O., & Pitk�nen, U. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542550 · Cited by 71
Harrison, S. A., & Bacon, B. R. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.08.005 · Cited by 66
Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patients
Lamminpää, A., Pukkala, ., Teppo, L., & Neuvonen, P. J. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0429-6 · Cited by 60
The Perturbation of Apoptosis and Mitosis by Drugs and Xenobiotics
Hasmall, S. C., & Roberts, R. A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00058-8 · Cited by 54
Enhancement by iron of hepatic neoplasia in rats caused by hexachlorobenzene
Smith, A. G., Carthew, P., Francis, J. E., Cabral, J. R. P., & Manson, M. M. (1993) · Carcinogenesis · doi:10.1093/carcin/14.7.1381 · Cited by 41
Carthew, P., & Smith, A. G. (1994) · Journal of Applied Toxicology · doi:10.1002/jat.2550140610 · Cited by 29
CANCER BIOLOGY: Reversibility of promoter induced hepatic focal lesion growth in mice
Kolaja, K. L., Stevenson, D. E., Walborg, E. F., et al. (1996) · Carcinogenesis · doi:10.1093/carcin/17.7.1403 · Cited by 28
Satoh, K., Itoh, K., Yamamoto, M. P., Tanaka, M., Hayakari, M., Ookawa, K., Yamazaki, T., Sato, T., Tsuchida, S., & Hatayama, I. (2002) · Carcinogenesis · doi:10.1093/carcin/23.3.457 · Cited by 27
Inherited metabolic liver disease
Schilsky, M. L., & Fink, S. A. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000218957.63311.0e · Cited by 18
Greaves, P., Clothier, B., Davies, R., Higginson, F. M., Edwards, R., Dalton, T. P., Nebert, D. W., & Smith, A. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.136 · Cited by 14
Cj, P. (1994) · PubMed · Cited by 14
Andersen, M. E., Brusick, D., Cohen, S., Dragan, Y. P., Frederick, C. B., Goodman, J. I., Hard, G. C., Meek, B., & O’Flaherty, E. J. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8496 · Cited by 14
Self-citationInherited metabolic liver disease
Schilsky, M. L., & Oikonomou, I. K. (2005) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000159821.78532.21 · Cited by 10
Cited by
IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans
Boobis, A. R., Doe, J. E., Heinrich-Hirsch, B., (Bette) Meek, M. E., Munn, S., Ruchirawat, M., Schlatter, J., Seed, J., & Vickers, C. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440701749421 · Cited by 542
Self-citationIPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans
Boobis, A. R., Cohen, S. M., Dellarco, V., McGregor, D., Meek, M. E. (., Vickers, C., Willcocks, D., & Farland, W. (2006) · Critical Reviews in Toxicology · doi:10.1080/10408440600977677 · Cited by 463
Self-citationOmiecinski, C. J., Vanden Heuvel, J. P., Perdew, G. H., & Peters, J. M. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq338 · Cited by 369
Rodricks, J. V., Swenberg, J. A., Borzelleca, J. F., Maronpot, R. R., & Shipp, A. M. (2010) · Critical Reviews in Toxicology · doi:10.3109/10408441003667514 · Cited by 292
Elcombe, C. R., Peffer, R. C., Wolf, D. C., Bailey, J., Bars, R., Bell, D., Cattley, R. C., Ferguson, S. S., Geter, D., Goetz, A., et al. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2013.835786 · Cited by 265
Metadata
- Authors
- Holsapple, M. P., Pitot, H. C., Cohen, S. H., Boobis, A. R., Klaunig, J. E., Pastoor, T., Dellarco, V. L., & Dragan, Y. P.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-10-12
- Volume
- 89
- Issue
- 1
- Pages
- 51-56
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2145479935
- Cited by
- 264
- References
- 33
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.